Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Risk of Recurrent CeAD After Pregnancy
NCT06258109 · View on ClinicalTrials.gov ↗
Study Summary
Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.
Conditions Studied
Study Locations (12)
Other
- Stroke Unit Sanatorio Allende — Córdoba
- Helsinki University Central Hospital — Helsinki
- Charité Universitätsmedizin, Centrum für Schlaganfallforschung — Berlin
- Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern — Munich
- Hadassah-Hebrew University Medical Center — Jerusalem
- Neurology Clinic, University of Brescia — Brescia
- Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez — Mexico City
- University Hospital Basel, Stroke Center — Basel
- University Hospital Zurich, Stroke Center — Zurich
Utah
- University of Utah — Salt Lake City
Virginia
- University of Virginia — Charlottesville
Tyrol
- Department of Neurology, Medical University of Innsbruck — Innsbruck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-07-01 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06258109
The ClinicalTrials.gov registry entry for NCT06258109 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospital, Basel, Switzerland, which has 10 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Pregnancy Complications appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06258109 reports 12 study locations spanning 4 distinct geographic areas — top geographies include Other, Utah, Virginia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06258109 about?
NCT06258109 is a clinical study titled "Risk of Recurrent CeAD After Pregnancy". Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint:...
What is the current status of trial NCT06258109?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-01-01. Estimated completion is 2025-07-01.
What conditions does trial NCT06258109 study?
This clinical trial studies the following conditions: Pregnancy Complications, Cervical Artery Dissection. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT06258109?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 10 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06258109 being conducted?
This trial has 12 study locations across Utah, Virginia, Tyrol. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.